Immunogenicity and safety of an inactivated COVID-19 vaccine (CoronaVac®) co-administered with an inactivated enterovirus type 71 vaccine (Inlive®): A phase 4, randomized, controlled trial

• Hoofdauteurs: Yajun Shu (Auteur), Zhuoqun Sun (Auteur), Fan Gao (Auteur), Zhuhang Huang (Auteur), Xing Meng (Auteur), Shaomin Chen (Auteur), Qun Shu (Auteur), Lianhao Wang (Auteur), Hengming Zhang (Auteur), Zhifang Ying (Auteur), Jikai Zhang (Auteur)
• Formaat: Boek
• Gepubliceerd in: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

This study aimed to provide evidence for co-administration of the COVID-19 and EV71 vaccines in children aged 3 to 5 years. We conducted a phase 4, open-label, randomized, and controlled study. A total of 520 children were randomly allocated to two groups: Group C received the COVID-19 and EV71 vacc...